ExperimentHiC in situ Hi-C on B cell derived cell line with MboI

in situ Hi-C4DNEX279YP3H
released
View JSON

in situ Hi-C on 24 hour activated B cells, treated with flavopiridol (4 hour) to inhibit transcription Replicate:GSM3138965_Vian-2018-HIC026

   November 27th, 2018 at 6:19pm
Source Publication
The Energetics and Physiological Impact of Cohesin Extrusion.
Vian L, Pekowska A, et al., Cell 2018

Properties  

Experiment Type 
in situ Hi-C
Follows SOP 
No
Biosample 
4DNBSX3S419H
Digestion Enzyme 
MboI
Biosample Modifications 
None
Biosample Treatments 
LPS (Sigma) treatment (50.0 μg/mL, 24.0h) and IL-4 (Sigma) treatment (2.5 ng/mL, 24.0h) and anti-CD180 (RP105) antibody, BD PharMingen treatment (0.5 μg/mL, 24.0h) and flavopiridol treatment (1.0 μM, 4.0h)
Biosample Biosource 
B cell derived cell line - 4DNSRA3JY5KY

Experiment SetOpen In Search View

Initializing...